ASP Isotopes is trading 10.51% down at $1.92, with the decline’s specific catalyst unconfirmed. - No company-specific announcement or report located on October 19 directly explains the decline. - The latest located company announcement was an October 15 binding agreement for a subsidiary’s HALEU joint venture with Necsa. - Broader market signals were mixed: technology shares rebounded and the Nasdaq rose while ASP Isotopes fell.